Tag: public

  • A Growing Public Health Debate

    A Growing Public Health Debate

    In modern healthcare, trust is everything. Patients put their lives in the hands of medical professionals with the belief that expertise, compassion, and ethical duty will ensure their well-being. But when that trust is broken, the consequences can be devastating physically, emotionally, and financially. Across the United States, medical negligence has emerged as one of the most pressing and controversial public health debates of our time. For families who have lost loved ones to such failures, reaching out to an experienced Wrongful Death Lawyer often becomes a crucial step toward seeking justice and accountability.

    The Scale of the Problem: When Healthcare Becomes Hazardous

    Medical negligence isn’t just an isolated issue; it’s a national epidemic. According to a study from Johns Hopkins Medicine, medical errors are the third leading cause of death in the United States, claiming more than 250,000 lives annually. This staggering statistic underscores the urgent need for reform, transparency, and patient empowerment within the healthcare industry.

    Behind those numbers are countless stories of ordinary people who entered hospitals for routine care and never returned home. Whether through misdiagnosed illnesses, anesthesia mistakes, or neglected infections, these tragedies expose vulnerabilities in a system that often prioritizes efficiency and cost over patient safety. The issue transcends individual practitioners and reflects systemic weaknesses in communication, accountability, and oversight.

    What makes medical negligence especially complex is its invisibility. Unlike dramatic crimes or visible accidents, the harm often unfolds quietly within sterile hospital walls. It can take weeks or even months before a patient or their family realizes that an avoidable mistake caused irreversible damage.

    The Legal Landscape: Where Accountability Meets Resistance

    Holding healthcare institutions accountable isn’t simple. Medical malpractice law sits at the intersection of ethics, law, and economics, where powerful interests often collide. In theory, victims have the right to pursue compensation through civil litigation. In practice, however, the road to justice is riddled with obstacles: high legal costs, expert witness requirements, and aggressive defense strategies by hospital insurers.

    According to data from the National Practitioner Data Bank (NPDB), fewer than 20 percent of patients who experience medical errors ever file claims. Of those who do, many face years of litigation before achieving a resolution. Hospitals and insurers often settle cases quietly, shielding systemic problems from public scrutiny.

    This lack of transparency undermines patient trust and stifles reform. Moreover, certain states have enacted medical malpractice caps that limit the damages victims can recover, regardless of the severity of their suffering. These caps, intended to prevent “frivolous lawsuits,” often end up denying full justice to legitimate victims, especially in wrongful death cases involving children, the elderly, or low-income individuals. Yet, despite these barriers, successful malpractice cases play a critical role in shaping public health policy. Each verdict or settlement sends a clear message: negligence has consequences.

    Common Forms of Medical Negligence

    Medical negligence can manifest in many forms, each with devastating outcomes. Some of the most common include misdiagnosis, surgical errors, medication mistakes, birth injuries, and failure to obtain informed consent.

    Misdiagnosis remains one of the deadliest forms of negligence. A report by the Agency for Healthcare Research and Quality (AHRQ) found that diagnostic errors contribute to nearly 10 percent of patient deaths. Missing a cancer diagnosis, for example, can mean the difference between a treatable illness and a terminal condition.

    Surgical negligence, on the other hand, can include leaving instruments inside patients, operating on the wrong body part, or causing internal damage through carelessness. Such errors often result in long-term disability or death, yet they’re entirely preventable with proper protocols.

    The Ethical Dilemma: Balancing Compassion and Consequence

    One of the most challenging aspects of the medical negligence debate lies in balancing compassion for healthcare workers with accountability for their actions. Medicine is a demanding field, and professionals often work under immense pressure. Fatigue, understaffing, and systemic inefficiencies can all contribute to mistakes.

    However, recognizing systemic pressures doesn’t absolve individuals or institutions from responsibility. When errors occur, ethical practice demands honesty, transparency, and restitution. Unfortunately, many hospitals choose the opposite route: concealing mistakes to avoid liability. This “culture of silence” not only delays justice but also perpetuates unsafe conditions.

    The Institute for Healthcare Improvement (IHI) has advocated for a “just culture” in medicine, one that differentiates between human error and reckless behavior. The goal is not to punish honest mistakes but to foster an environment where learning replaces fear and accountability replaces denial.

    The Role of Legal Advocacy in Driving Change

    Attorneys who specialize in medical malpractice and wrongful death are more than litigators; they are advocates for systemic reform. Each case they take on serves as a check against complacency and as a reminder that negligence has ripple effects beyond individual victims.

    A dedicated Wrongful Death Lawyer can bring hidden patterns of misconduct to light, whether it’s a hospital cutting corners on staffing or a surgeon ignoring safety protocols. By holding negligent parties financially and legally accountable, these lawyers indirectly save lives, forcing institutions to prioritize prevention over damage control.

    Legal victories in medical negligence cases often lead to procedural reforms. Hospitals may adopt stricter verification processes, implement digital prescription systems to reduce human error, or expand patient consent protocols. In this sense, litigation becomes not only a tool for justice but also a mechanism for progress.

    Toward a Culture of Accountability

    Ultimately, medical negligence and accountability aren’t opposing forces; they are two sides of the same coin. True progress in healthcare depends on acknowledging failures and learning from them. The conversation about medical negligence should not center solely on blame but on building systems resilient enough to prevent harm in the first place.

    That means empowering patients with information, protecting whistleblowers, and encouraging healthcare providers to report mistakes without fear of retribution. It also means supporting those who have suffered due to negligence through compassionate and effective legal representation.

    As the debate continues, one principle remains clear: accountability is not a punishment, it’s a promise. A promise that every patient’s life has value, every mistake has a lesson, and every act of negligence has a consequence. And through that promise, we can build a healthcare system where trust, safety, and justice coexist.

    Source link

  • Robin Avalos on Shaping a Public Health Response to Substance Risks

    Robin Avalos on Shaping a Public Health Response to Substance Risks

    The United States faces a pervasive crisis too often overlooked. Addiction, unintentional exposure, and gaps in education and access quietly undermine families and communities. Beneath everyday life lies a problem demanding clearer attention. In response, Robin Avalos, MMS, PA-C, brings clinical expertise and advocacy to advance practical, evidence-informed solutions.

    Avalos brings training and on-the-ground experience to conversations many find difficult. She began her career as an EMT, studied neuroscience and biology, and completed graduate work focused on correctional healthcare. Working in jails, emergency departments, and group homes exposed her to how fragmented responses and missed screenings can leave people unprotected. Personal tragedy, family members lost to overdose, sharpened her commitment to change and to compassionate, evidence-informed care.

    Her insights stem from years of clinical practice and a refusal to simplify a complex problem. Avalos has reconnected people to treatment through telehealth, coordinated medication access, and trauma-informed follow-up. She has stood in school offices and staff rooms asking practical questions about prevention and screening and pushed for policies that treat safety as routine rather than punitive. “We can approach this like public health: small steps that keep people alive and ready to get help,” she says, urging a steady, human-centered response.

    The broader landscape helps explain why that steadiness matters. National data show overdose counts have been tragically high and that illicit synthetic opioids such as fentanyl are central drivers of the crisis. Laboratory testing and law enforcement data also document how lethal contamination of counterfeit pills and other supplies has worsened risk.

    Within that reality, Avalos highlights an important mismatch. The tools to obtain dangerous substances are often easy to reach, while practical testing and reliable, nonjudgmental information aren’t always in place. Fentanyl test strips, low-cost, rapid screening tools that detect fentanyl in a variety of drug forms, are endorsed as a harm-reduction option by health agencies and can be paired with naloxone distribution and counseling to lower risk.

    Avalos frames these steps as practical prevention rather than punishment. “A simple test can change a decision in a moment, and that moment can be life-saving,” she says. For instance, a study shows that people who use fentanyl test strips are more likely to engage in risk-reduction behaviors. “When testing is paired with clear information and access to rescue medication, those benefits can increase,” Avalos adds.

    Yet distribution and adoption remain uneven due to different policies and varying views about harm reduction across communities. Avalos sees two linked priorities. First, improve screening and immediate safeguards in places where young people and families spend time, such as schools, community centers, and primary care clinics, without turning every conversation into a punitive exam.

    Second, invest in education so parents, teachers, and clinicians can recognize subtle signs of exposure and respond with curiosity and care rather than blame. Avalos urges school leaders and health officials to make sensible, age-appropriate changes so safety becomes part of routine care rather than an emergency-only reaction. It’s worth noting that some jurisdictions have begun to pilot such approaches and policy changes in schools.

    Her approach is intentionally practical. Streamline access to lifesaving interventions, ensure continuity of care after acute events, and remove barriers that make follow-up treatment difficult. Screening should complement, not replace, clinical judgment and therapeutic support. After all, it’s an entry point to care rather than an end. “We’re not trying to shame anyone,” Avalos says. “We want a simple way for people to look after one another and then walk together toward recovery.”

    Addressing this crisis will not be quick, but Avalos’s advocacy models a steady pathway. It asks for more listening, better training for adults who care for young people, and small structural adjustments that reduce harm and create clear pathways back to treatment. For policymakers, clinicians, educators, and parents, her work points to pragmatic actions. Normalize harm reduction where appropriate, expand screening and naloxone access, and commit to honest, nonpunitive education that keeps communities safer. She remarks, “Start with safety, keep doors open to care, and treat one another with the decency we all deserve.”

    Source link

  • HHS Overhauls Vaccine Advisory Committee to Restore Public Trust

    HHS Overhauls Vaccine Advisory Committee to Restore Public Trust

    WASHINGTON — The U.S. Department of Health and Human Services (HHS) announced Monday that it has removed all 17 members of the Advisory Committee on Immunization Practices (ACIP), citing a need to restore public trust in federal vaccine recommendations.

    The sweeping change, directed by HHS Secretary Robert F. Kennedy Jr., comes as part of a broader initiative to increase transparency, reduce conflicts of interest, and realign public health decisions with impartial scientific standards.

    “Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda,” Kennedy said. “The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies.”

    The move follows President Donald Trump’s “Restoring Gold Standard Science” executive order, which mandates the reconstitution of scientific advisory bodies to ensure their independence from industry and political influence. The HHS statement noted that 13 of the 17 committee members were appointed in 2024 by the Biden administration, which would have extended their terms into 2028.

    “A clean sweep is necessary to reestablish public confidence in vaccine science,” Kennedy said. “ACIP’s new members will prioritize public health and evidence-based medicine. The Committee will no longer function as a rubber stamp for industry profit-taking agendas.”

    The committee, which plays a critical role in determining national immunization schedules, will convene its next meeting June 25–27 at the CDC headquarters in Atlanta. New members are currently under consideration, according to HHS.

    “The entire world once looked to American health regulators for guidance, inspiration, scientific impartiality, and unimpeachable integrity,” Kennedy added. “Public trust has eroded. Only through radical transparency and gold standard science, will we earn it back.”

    Source link

  • FBI Asks Public for Tips on Medical Institutions Providing Gender-Affirming Surgeries on Kids

    FBI Asks Public for Tips on Medical Institutions Providing Gender-Affirming Surgeries on Kids

    The Federal Bureau of Investigation (FBI) is asking the public for any tips regarding medical institutions that are performing gender-affirming surgeries on children.

    President Donald Trump’s administration has placed gender-affirming care among transgender youth under scrutiny on the second day of Pride Month. “Help the FBI protect children,” the agency wrote, adding that they want to hold accountable those who “mutilate” kids under the guise of gender-affirming care.

    FBI Cracks Down on Gender-Affirming Surgeries on Children

    The Republican leader’s policies have continued to target the transgender community, restricting access to various services, such as gender-affirming healthcare. This comes as the procedure is rarely done in adolescents and is considered only on a case-by-case basis.

    Additionally, the majority of youth who receive these kinds of procedures report high levels of satisfaction, saying they have improved mental health and low levels of regret. Last week, Medicare wrote that selected hospitals sought billing codes and projected revenue from treating gender dysphoria in children, according to Axios.

    It asserted that gender-affirming care for minors has significant risks without providing substantial evidence to back up its claims. This caused it to draw scrutiny among major medical associations.

    A spokesperson for the Human Rights Campaign, Laurel Powell, said that healthcare for transgender youth is simply healthcare. She argued that trying to weaponize the FBI against American doctors who are doing their jobs is detrimental to parents who want their kids to thrive.

    The FBI’s request to the public comes as youth gender-affirming care has become illegal in 27 states across the country. Additionally, 17 states are facing legal challenges over the restrictions, putting them temporarily on hold, The Hill reported.

    Targeting the Transgender Community

    When Trump signed an executive order where he recognized male and female as the only two sexes, he also directed federal agencies to stop promoting the concept of gender transition. The Department of Health and Human Services (HHS), under the Republican leader’s directives, adopted the position that it “rejects gender ideology.”

    The development comes as the Trump administration passed a tax bill that bans Medicaid from covering transition-related care. Additionally, the legislation prohibits marketplace plans that are available under the Affordable Care Act from covering transgender care as an essential health benefit.

    The bill would have initially banned Medicaid from covering “gender transition procedures” for minors. However, House Republican leadership introduced an amendment that removed the word “minors” and the words “under 18 years of age.”

    The amendment later passed the GOP-led Rules Committee and the full House passed it the day after, as per NBC News.



    Originally published on parentherald.com

    © {{Year}} ParentHerald.com All rights reserved. Do not reproduce without permission.

    Source link

  • Indiana Doctors Go To Court To Keep Terminated Pregnancy Reports From Being Released To The Public

    Indiana Doctors Go To Court To Keep Terminated Pregnancy Reports From Being Released To The Public

    Two abortion providers in Indiana advocating against the release of individual terminated pregnancy reports have taken the matter to court, filing a lawsuit in Marion County to keep the records private.

    Licensed OB-GYN physicians Caitlin Bernard and Caroline Rouse filed the suit to prevent the Indiana Department of Health from releasing documents relating to terminated pregnancies under Indiana’s Access to Public Records Act, stating that such records are exempt and do not have to be divulged, Inside Indiana Business reported.

    If released, the reports would not reveal the names of the patients who terminated pregnancies, but would include other personal information such as age, race and county of residence. The reports would also list the name of the physician who performed the abortion.

    “We are once again in court defending our patients and their right to privacy,” Bernard and Rouse said in a joint statement, as reported by The Hill.

    “Everyone receiving medical care deserves to have their personal health decisions and pregnancy outcomes protected. There is no reason to release this sensitive information to the public. We will keep fighting to protect patients’ privacy and the trust between doctors and patients,” they continued.

    Bernard gained national attention after speaking out about a patient who she had helped to receive an abortion in 2022: a 10-year-old girl from Ohio who had reportedly been sexually assaulted.

    The Indiana Department of Health stopped releasing individual reports of terminated pregnancies following the state’s implementation of a near-total abortion ban, continuing only to release aggregate reports of terminated pregnancies within the state.

    From July to September of 2023, the IDOH reported 764 abortions. Only 17 of these were performed after August when abortion bans took effect. The agency then addressed concerns that identifying reports could be “reverse-engineered” to identify patients who terminated pregnancies due to the small number of abortions being carried out within the state.

    “Given that the report is populated with information that could be reverse engineered to identify patients — especially in smaller communities — (IDOH argues) that the required quarterly reports should suffice in terms of satisfying any disclosure and transparency considerations,” the December informal opinion from Public Access Counselor Luke Britt said.

    Pro-life advocacy group Voices for Life continued to sue the state of Indiana, demanding the release of individual reports. Voices for Life further stated it would file an appeal after the case was dismissed by a Marion County judge in 2024. However, in January 2025, Indiana’s newly elected Republican Governor, Mike Braun, demanded that the reports be publicized through executive order.

    IDOH, which settled and agreed to publicize the records, stated that they would make redactions to the reports that “adequately protect personal health identifiers and that do not inhibit examination of the terminated pregnancy reports to determine whether a physician performed an abortion in accordance with Indiana law,” per the Indiana Capitol Chronicle.

    The court has yet to set a hearing for the suit brought forward by Bernard and Rouse.

    Originally published by Latin Times.

    Source link

  • Alumni News: Winter 2024 | Harvard T.H. Chan School of Public Health

    Alumni News: Winter 2024 | Harvard T.H. Chan School of Public Health

    Marty Markay

    Harvard Chan alum Marty Makary chosen to lead FDA

    Martin “Marty” Makary, MPH ’98, will be nominated by President-elect Donald Trump to be commissioner of the Food and Drug Administration. If confirmed by the Senate, Makary would lead the agency responsible for regulating the nation’s food supply, vaccines, medicines and medical devices, cosmetics, tobacco, and biologics. Makary is a physician who specializes in surgical oncology and currently serves as chief of islet transplant surgery at the Johns Hopkins School of Medicine. He’s also a member of the National Academy of Medicine; a former leader of the World Health Organization Patient Safety Program; a medical and health policy researcher who has published more than 250 peer-reviewed articles; and an author who has written three New York Times best-selling books on health care. Read more

    Alumni win re-election to U.S., Iowa House seats

    Two alumni were re-elected to their seats in November: U.S. Rep. Raul Ruiz, MPH’07, of California’s District 25 and State Rep. Megan Srinivas, MPH ’15, of Iowa’s District 30.

    If you know of other alumni who ran in this election, please let us know.

    Epidemiology Alumni Q&A: Raymond Neutra
    Raymond Neutra, MPH ’69, DrPH ’74, has had a public health career in environmental medicine and epidemiology and has held leadership roles in academia and the public sector. Currently he is the president of the Neutra Institute for Survival Through Design, which promotes creative research and design that benefits people and the planet. He spoke with the Department of Epidemiology about his time as a graduate student and offered advice to current students.

    Disentangling complex medical outcomes

    Biostats alumna Linda Valeri, PhD ’13, was recently profiled  by Harvard Catalyst about the pilot funding that was critical to her research career. Valeri is an assistant professor in biostatistics at the Columbia University Mailman School of Public Health.

    Serving the community

    Deborah Cook Kaliel,SM ’06, recently spoke with The Amherst Student about her work with the U.S. Agency for International Development building sustainable HIV programs across the world.

    Alumni notes

    1980

    Jane Newburger, MPH, associate chair for academic affairs in the department of cardiology at Boston Children’s Hospital and Commonwealth Professor of Pediatrics at Harvard Medical School, received the 2024 Eugene Braunwald Academic Mentorship Award at the American Heart Association’s Scientific Sessions 2024 in November.

    1992

    Friday Okonofua, Takemi Fellow, was elected to the National Academy of Medicine in October. Okonofua is the leader of the Center of Excellence in Reproductive Health Innovation, University of Benin, in Nigeria. He has led research on maternal mortality prevention, with impact on policies and programming in African countries.

    1994

    Christine Sang, MPH, was named to the Clinical Advisory Board of Allay Therapeutics in October. She is associate professor of anesthesia at Harvard Medical School and the founding director of the Translational Pain Research program at Brigham and Women’s Hospital.

    1999

    Jessica Kahn, MPH, became the senior associate dean for clinical and translational research and director of the Block Institute for Clinical and Translational Research at Albert Einstein College of Medicine in October. She previously served as co-director of the Center for Clinical and Translational Science and Training and professor of pediatrics at the University of Cincinnati and as the founding associate chair of academic affairs and career development at Cincinnati Children’s.

    2002

    Lu Tian, SD, presented this year’s Lagakos Distinguished Alumni Award on “Adaptive Prediction Strategy with Individualized Variable Selection” in October. He is professor of biomedical data science at Harvard Medical School.

    2004

    Ashwin Vasan, SM, who led New York City through the COVID-19 pandemic as its 44th  Health Commissioner, was named the James McCune Smith Distinguished Fellow for the School of Global Health at Meharry Medical College in October.

    Kaja LeWinn, SM, SD ’07, professor of psychiatry and behavioral sciences at the University of California, San Francisco, received the Trinity College President’s Award for Science and Innovation in October. LeWinn’s research focuses on children’s neurodevelopment and mental health.

    2012

    Alisa Stephens-Shields,PhDassociate professor of biostatistics at the University of Pennsylvania Perelman School of Medicine, was the recipient of the 2024 Myrto Lefkopoulou Distinguished Lectureship in September. Stephens-Shields was recognized for her great capacity as both a methodologic and collaborative biostatistician and as a leader impacting health, statistical education, and inclusion in the field.

    2017

    Huda Zoghbi, SD, was invested as a member of the American Academy of Sciences and Letters in October. She is distinguished service professor at Baylor College of Medicine, an investigator with the Howard Hughes Medical Institute, and founding director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital. 

    2021

    Irina Degtiar, PhD, received both the 2024 ASA Outstanding Statistical Application Award and the Manning Memorial Award for the Best Research in Health Econometrics for her dissertation paper. She currently is a statistician at Mathematica Research.

    2024

    Esias Bedingar, was selected to join WHO’s Global Action for Measurement of Adolescent Health (GAMA) Advisory Group. As a part of this 20-member group, he will help advise WHO and UN partners on research priorities and strategies to improve adolescent health measurement.

    Wedding

    Anup Kanodia, MPH ’08,married Rupal Ramesh Shah in June 2023 in Columbus, Ohio. Several Harvard Chan School classmates attended the ceremony, which incorporated America, Indian, and African traditions. Kanodia runs a medical practice in the Columbus area. See a photo feature on the wedding that ran in the Columbus Dispatch.

    In memoriam

    Evelyn Benson, MPH ’55, died on October 20 at 100. She was a rural public health nurse in Ohio and a community gerontological nurse in Chester, Penn. She later taught at Widener College and Temple University and was assistant dean of the School of Nursing at LaSalle University when she retired in 1994. She co-authored the textbook Community Health and Nursing Practice and wrote dozens of articles on public health nursing, international nursing, and nursing history. Read her obituary.

    Ralph Hoover, MPH ’62, died June 9 at 92. He was a physician and public health officer in Waterloo, Iowa, and in retirement went back to school to become a lawyer. He founded a law firm specializing in health care law. Read his obituary.

    David Wheeler, MPH ’09, died June 29 at 51. He was an internationally recognized biostatistician with a focus on spatial, cancer, and environmental epidemiology. He joined the Biostatistics Department at the School of Medicine at Virginia Commonwealth University in 2011 and was promoted to a full professorship in 2023. Read his obituary.

    DrPH alumni news

    Read alumni news from the DrPH program.

    Harvard Chan School alumni in action

    Tell us about your life since Harvard Chan School.


    Last Updated

    Get the latest public health news

    Stay connected with Harvard Chan School

    Source link

  • Promoting Covid, Flu Vaccines to Public Quietly Banned by Louisiana Department of Health: ‘Unconscionable’

    Promoting Covid, Flu Vaccines to Public Quietly Banned by Louisiana Department of Health: ‘Unconscionable’

    Louisiana public health officials are no longer permitted to promote vaccines, including those against illnesses such as COVID-19 and the flu, to members of the public in a new policy that was covertly implemented in the state.

    The policy was considered during two Louisiana Department of Health meetings held on Oct. 3 and Nov. 21, reported NPR. Employees who discussed the policy under anonymity revealed that it was to be quietly implemented and was never written down.

    The limits placed upon public health employees are far-reaching. They are forbidden from distributing press releases, giving interviews, holding vaccine events, giving presentations or creating social media posts that advocate for the benefits of vaccines and encourage members of the public to get them.

    The policy comes after President-Elect Donald Trump named former presidential candidate Robert F. Kennedy Jr. as his pick to lead the Department of Health and Human Services. RFK Jr., a known anti-vaxxer, has frequently perpetuated myths about vaccines including one debunked conspiracy theory that points to vaccines as the cause of autism amongst children.



    A city in Florida voted to remove fluoride from its water supply, citing Robert F. Kennedy, Jr.’s crusade against the chemical.
    Rebecca Noble/Getty Images


    Trump has stayed firm in his nomination of RFK Jr., stating that he is “much less radical than you would think” and that he has “a very open mind.”

    Staff at Louisiana’s health department have voiced frustrations with the new policy, with many of them expressing concern about the possible spread of illness as a result of the new rule.

    “Do they want to dismantle public health?” one employee at the health department said.

    “We’re really talking about deaths,” said another. “Even a reduction in flu and COVID vaccines can lead to increased deaths.”

    “It’s a step backwards,” said Kimberly Hood, who led the Office of Public Health, a subunit of the health department, from 2021 to 2022. “It’s a medical marvel that we’re fortunate enough to live in a time where these vaccines are available to us, and to not make use of that tool is unconscionable.”

    Originally published by Latin Times.

    Source link

  • Trump Pick for Public Health Chief Opposed COVID Lockdown, Wanted People to Get Infected on Purpose

    Trump Pick for Public Health Chief Opposed COVID Lockdown, Wanted People to Get Infected on Purpose

    President-elect Donald Trump‘s latest leadership pick for the National Institutes of Health once published an open letter slamming the COVID-19 lockdown, while promoting “herd immunity” as a solution to the pandemic.

    “Together, Jay and RFK Jr. will restore the NIH to a Gold Standard of Medical Research as they examine the underlying causes of, and solutions to, America’s biggest Health challenges, including our Crisis of Chronic Illness and Disease,” Trump wrote in a statement released Tuesday, AP News reported.

    Dr. Jay Bhattacharya, a professor of medicine, economic and health research policy at Stanford University whose research focuses not on the science of health but the economics of health care, was shadow-banned on Twitter after he joined in 2021 and started sharing misinformation regarding the pandemic, according to reporting by the Wall Street Journal. His account was fully reinstated after Elon Musk bought the platform and invited Bhattacharya to defend his output.

    During the COVID-19 pandemic, and before vaccines were available, Bhattacharya encouraged “low-risk” people to live normally to build immunity to the infectious disease while people at higher risk were protected in an open letter dubbed the Great Barrington Declaration, written by three medical experts, including Bhattacharya, in October 2020, AP News reported.

    At the time, then-NIH Director Dr. Francis Collins called the letter dangerous and “not mainstream science.”

    “I think the lockdowns were the single biggest public health mistake,” Bhattacharya later said during a panel discussion organized by Florida Gov. Ron DeSantis in March 2021.

    The Senate will have to approve Bhattacharya’s appointment before officially takes office.

    Originally published by Latin Times

    Source link